{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 458270895
| type              = mab
| image             = 
| alt               = 
| mab_type          = mab
| source            = u
| target            = [[integrin]] alpha-V
| tradename         =  
| Drugs.com         =
| MedlinePlus       =
| pregnancy_AU      = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US      = <!-- A / B            / C / D / X -->
| pregnancy_category=  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled -->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status      = 
| routes_of_administration = 
| bioavailability   = 
| protein_bound     = 
| metabolism        = 
| elimination_half-life = 
| excretion         = 
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number        = 725735-28-4
| ATC_prefix        = none
| ATC_suffix        = 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = GQE1BJE2NI
| PubChem           = 
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank          = 
| KEGG = D09631
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| C=6468 | H=10008 | N=1744 | O=2006 | S=40
| molecular_weight = 145.6 kg/mol
}}

'''Intetumumab''' is a human monoclonal antibody that was being studied for the treatment of solid tumors.<ref>{{cite web|title=Statement On A Nonproprietary Name Adopted By The USAN Council: Intetumumab|publisher=[[American Medical Association]]|url=http://www.ama-assn.org/ama1/pub/upload/mm/365/intetumumab.pdf}}</ref>

Intetumumab was developed by [[Centocor]], Inc.

Phase II clinical trials for treatment of [[melanoma]] and [[prostate cancer]] were in progress when development of the drug was discontinued.<ref name="Adis">{{cite web|title=Intetumumab|url=http://adisinsight.springer.com/drugs/800019252|website=AdisInsight|accessdate=30 January 2017}}</ref>

== References ==

<references/>

{{monoclonals for tumors}}
[[Category:Janssen Biotech]]
[[Category:Experimental cancer drugs]]


{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}